Safety and efficacy of the HilumDirect uVATS for small cell lung cancer: a retrospective study
The HilumDirect uVATS resection can be safely performed by experienced surgeons with minimal invasiveness. Our findings suggest that selected SCLC patients, particularly those with positive lymph nodes, may benefit from this approach. However, further studies are warranted to confirm these results.
Authors
- Jingwei Liu (ORCID: https://orcid.org/0000-0003-1981-0436)
- Jian Li (ORCID: https://orcid.org/0000-0002-5807-2360)
- Shijie Zhang (ORCID: https://orcid.org/0000-0001-6455-5185)
- Xining Zhang (ORCID: https://orcid.org/0000-0001-8959-8405)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Frontiers in Surgery
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3389/fsurg.2025.1666087
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00